Candesartan for depression in bipolarity

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with placebo. Direct benefit is not guaranteed.

This study is sponsored by Deakin University. Based on the sponsor name or official registry information, it appears to be a university. Collaborators include University of Melbourne, University of Sydney, Barwon Health, Eastern Health, The Melbourne Clinic, Albert Road Clinic, Royal North Shore Hospital, Toowong Specialist Clinic. You should verify the details in the official registry record.

This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is Phase 2 / Phase 3. Earlier-phase studies are often more focused on safety, dose, or feasibility, while later-phase studies usually involve more participants and more information about the intervention. The official source record gives the most accurate details. The planned or actual enrollment is 240 participants. Larger studies may provide more information about how the intervention performs across a wider group, but size alone does not prove that a study is right for you. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.